Inhibitor Therapeutics, Inc.

Inhibitor Therapeutics, Inc.

CBTE - Insider Information

Get informed when a big investor buys or sells

+ Follow
Market Cap$144.47M
Close$

Compare to Similar Companies

P/E RatioDividendsReturn on EquityPrice-to-SalesDebt-to-Equity
Inhibitor Therapeutics, Inc.Inhibitor Therapeutics, Inc.-4.2-101%--1

Insider Trades

Loading insider trades…

Congress Trades

Loading congress trades…

Share Statistics

Market cap$144.47 Million
Enterprise Value$147.37 Million
Earnings per Share$-0.01
Beta2.58
Outstanding Shares370,446,185

Return

Return on Equity101.16%ROE
Return on Assets-1288.11%
Return on Invested Capital2367.85%

Valuation & Multiples

P/E Ratio-4.19P/E Ratio
PEG24.49PEG
Price to Sales-Price to Sales
Price to Book Ratio-0.39Price to Book Ratio
Enterprise Value to Revenue-
Enterprise Value to EBIT-45.75
Enterprise Value to Net Income-47
Total Debt to Enterprise0.02
Debt to Equity-0.97Debt to Equity

Revenue Sources

No data

Institutional Sentiment (Put/Call)

No data available for the latest quarter.

Institutional Ownership

No data available for the latest quarter.

About Inhibitor Therapeutics, Inc.

8 employees
CEO: Francis E. O'Donnell Jr.

Inhibitor Therapeutics, Inc., established in 1992 and based in Tampa, Florida, is a pharmaceutical development enterprise. The company is dedicated to inventing and commercializing medical treatments for patients in the United States who...